The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

Objective. Primary percutaneous coronary intervention (PCI) is the best treatment for acute ST-elevation myocardial infarction (STEMI). Evidence is in favor of ticagrelor over clopidegrel in STEMI patients regarding the reduction of stent thrombosis risk during and after PCI. We compared initial thr...

Full description

Bibliographic Details
Main Authors: Amin Elahifar, Ali Rafati, Mohammad Javad Alemzadeh-Ansari, Yeganeh Pasebani, Behshad Naghshtabrizi, Younes Mohammadi, Seyed Kianoosh Hosseini
Format: Article
Language:English
Published: Hindawi Limited 2024-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2024/6632656
_version_ 1797316093974413312
author Amin Elahifar
Ali Rafati
Mohammad Javad Alemzadeh-Ansari
Yeganeh Pasebani
Behshad Naghshtabrizi
Younes Mohammadi
Seyed Kianoosh Hosseini
author_facet Amin Elahifar
Ali Rafati
Mohammad Javad Alemzadeh-Ansari
Yeganeh Pasebani
Behshad Naghshtabrizi
Younes Mohammadi
Seyed Kianoosh Hosseini
author_sort Amin Elahifar
collection DOAJ
description Objective. Primary percutaneous coronary intervention (PCI) is the best treatment for acute ST-elevation myocardial infarction (STEMI). Evidence is in favor of ticagrelor over clopidegrel in STEMI patients regarding the reduction of stent thrombosis risk during and after PCI. We compared initial thrombolysis in myocardial infarction (TIMI) flow in STEMI patients on ticagrelor vs. clopidogrel. Methods. This prospective cohort recruited 160 patients with acute STEMI, referred to the emergency department of Farshchian Heart Center, during March 2018–2019. Before angiography, the patients received clopidogrel (600 mg) or ticagrelor (180 mg) on top of aspirin. Initial TIMI flow was compared between the two groups as the primary outcome. A logistic regression was performed to calculate the predictors of initial TIMI flow. Analyses were performed using R, version 4.2.1. Results. In ticagrelor and clopidogrel groups, the mean ± standard deviation age of the patients was 59.46 ± 13.11 and 61.34 ± 11.08 years (p value = 0.33), respectively. In the ticagrelor and clopidogrel groups, initial TIMI flow grades were as follows: 0 : 50% and 71.2%, I: 26.2% and 16.2%, II: 12.5% and 10%, and III: 12.9% and 2.5%, respectively (p value = 0.005). Final TIMI flow grades were as follows: I: 26.2% and 16.2%, II: 7.5% and 13.8%, and III: 66.3% and 70%, respectively (p value = 0.41). Ticagrelor was associated with significantly higher initial TIMI flow grade compared to the clopidogrel group (adjusted odds ratio: 2.90 (95% CI: 1.51–5.72)). Conclusion. In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.
first_indexed 2024-03-08T03:14:13Z
format Article
id doaj.art-e6c5da975c3f46f2abac47f496c94dc6
institution Directory Open Access Journal
issn 2090-0597
language English
last_indexed 2024-03-08T03:14:13Z
publishDate 2024-01-01
publisher Hindawi Limited
record_format Article
series Cardiology Research and Practice
spelling doaj.art-e6c5da975c3f46f2abac47f496c94dc62024-02-13T00:00:02ZengHindawi LimitedCardiology Research and Practice2090-05972024-01-01202410.1155/2024/6632656The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort StudyAmin Elahifar0Ali Rafati1Mohammad Javad Alemzadeh-Ansari2Yeganeh Pasebani3Behshad Naghshtabrizi4Younes Mohammadi5Seyed Kianoosh Hosseini6Rajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterRajaie Cardiovascular Medical and Research CenterFarshchian Heart CenterDepartment of EpidemiologyFarshchian Heart CenterObjective. Primary percutaneous coronary intervention (PCI) is the best treatment for acute ST-elevation myocardial infarction (STEMI). Evidence is in favor of ticagrelor over clopidegrel in STEMI patients regarding the reduction of stent thrombosis risk during and after PCI. We compared initial thrombolysis in myocardial infarction (TIMI) flow in STEMI patients on ticagrelor vs. clopidogrel. Methods. This prospective cohort recruited 160 patients with acute STEMI, referred to the emergency department of Farshchian Heart Center, during March 2018–2019. Before angiography, the patients received clopidogrel (600 mg) or ticagrelor (180 mg) on top of aspirin. Initial TIMI flow was compared between the two groups as the primary outcome. A logistic regression was performed to calculate the predictors of initial TIMI flow. Analyses were performed using R, version 4.2.1. Results. In ticagrelor and clopidogrel groups, the mean ± standard deviation age of the patients was 59.46 ± 13.11 and 61.34 ± 11.08 years (p value = 0.33), respectively. In the ticagrelor and clopidogrel groups, initial TIMI flow grades were as follows: 0 : 50% and 71.2%, I: 26.2% and 16.2%, II: 12.5% and 10%, and III: 12.9% and 2.5%, respectively (p value = 0.005). Final TIMI flow grades were as follows: I: 26.2% and 16.2%, II: 7.5% and 13.8%, and III: 66.3% and 70%, respectively (p value = 0.41). Ticagrelor was associated with significantly higher initial TIMI flow grade compared to the clopidogrel group (adjusted odds ratio: 2.90 (95% CI: 1.51–5.72)). Conclusion. In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.http://dx.doi.org/10.1155/2024/6632656
spellingShingle Amin Elahifar
Ali Rafati
Mohammad Javad Alemzadeh-Ansari
Yeganeh Pasebani
Behshad Naghshtabrizi
Younes Mohammadi
Seyed Kianoosh Hosseini
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
Cardiology Research and Practice
title The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_full The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_fullStr The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_full_unstemmed The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_short The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
title_sort comparison of the initial timi flow grade in acute st elevation myocardial infarction patients receiving ticagrelor vs clopidogrel before undergoing primary percutaneous coronary intervention a prospective cohort study
url http://dx.doi.org/10.1155/2024/6632656
work_keys_str_mv AT aminelahifar thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT alirafati thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT mohammadjavadalemzadehansari thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT yeganehpasebani thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT behshadnaghshtabrizi thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT younesmohammadi thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT seyedkianooshhosseini thecomparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT aminelahifar comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT alirafati comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT mohammadjavadalemzadehansari comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT yeganehpasebani comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT behshadnaghshtabrizi comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT younesmohammadi comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy
AT seyedkianooshhosseini comparisonoftheinitialtimiflowgradeinacutestelevationmyocardialinfarctionpatientsreceivingticagrelorvsclopidogrelbeforeundergoingprimarypercutaneouscoronaryinterventionaprospectivecohortstudy